Search
for
Sort by
Research 241–270 of 1000+
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- BI35 A case of dupilumab-induced scalp psoriasis and review of the literature
- Sport als Risikofaktor und therapeutisches Prinzip in der Dermatologie
- Friend or foe: A systematic review of dupilumab and alopecia areata
- The COVID-19 pandemic and its skin effects
- Iron–Skin Axis: Exploring the Interplay between Iron Homeostasis and Skin Disorders
- <i>JAMA Dermatology—</i>The Year in Review, 2021
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- The use of dupilumab for the treatment of alopecia areata
- The use of cyclosporine in dermatology: Part I
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Common Skin Disorders in Pediatric Skin of Color
- EGFR Inhibitors and Cutaneous Complications: A Practical Approach to Management
- Ingestion of a dietary supplement resulting in selenium toxicity
- Sebaceous immunobiology - skin homeostasis, pathophysiology, coordination of innate immunity and inflammatory response and disease associations
- Epidemiology of Vitiligo – A Dual Population-Based Approach
- Erythroderma: clinical and etiological study of 88 cases seen in a tertiary hospital over 25 years
- Photosensitivity reaction induced by finasteride
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Clinical Application of Development of Nonantibiotic Macrolides That Correct Inflammation-Driven Immune Dysfunction in Inflammatory Skin Diseases
- The Effects of Changing Lifestyle and Daily Behaviours in the First Months of COVID-19 Outbreak on Dermatological Diseases: Retrospective Cross-Sectional Observational Study
- How does covid-19 affect the skin?
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma
- New small molecules in dermatology: for the autoimmunity, inflammation and beyond
- Nilontinib induced keratosis pilaris atrophicans
- Eczémas de contact atypiques ou sévères à l’huile essentielle de cannelle
- Inflammatory loops in the epithelial–immune microenvironment of the skin and skin appendages in chronic inflammatory diseases